KMED KraneShares Emerging Mkts Hlthcare ETF
Solactive EM Healthcare NR USD

NAV as of 13-May-2022

21.1100

4 Week: 20.70 - 23.79

52 Week: 20.70 - 36.93

Latest Closing Price

21.20

Premium / Discount

-1.29

Expense Ratio

0.8%

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the Solactive Emerging Markets Healthcare Index (the index). The fund will invest at least 80% of its total assets in components of the index, depositary receipts, representing such components, and securities underlying depositary receipts in the index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
KraneShares
Asset Under Management:
2,097,992
Launch Date:
28/08/2018
Asset Class:
Equity
Replication Method:
Physical-Sample
Number of Holdings:
146
Trading Currency:
USD
Style:
Large Growth
Region/Sector/Strategy:
Emerging Markets / N.A / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-24.111.46-16.48
1 Day-0.380.000.00
1 Week2.041.781.15
1 Month-11.226.04-1.86
3 Months-15.6411.77-1.33
6 Months-28.4915.08-1.89
1 Year-41.3220.34-2.03
2 Years-9.7830.95-0.32
3 Years0.4541.610.01
5 Years0.000.000.00
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.00000.00000.000012.308359.4163-21.7878
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.000086.00002.000099.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
N.A

Portfolio Data

Total Number of Holdings: 146

Number of Bond Holdings: 0

Number of Equity Holdings: 140

Total Market Value: 2,097,992

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Samsung BioLogics Co Ltd4.84141850136,642

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant28.85
Large49.77
Medium17.57
Small3.22
Micro0.26

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

25.8936

Price/Book*

3.2297

Price/Sales*

2.8415

Price/Cash Flow*

12.6218

Dividend Yield*

3.5846

Growth Measures

Long-Term Earnings

52.9534

Historical Earnings

26.7941

Sales Growth

17.2082

Cash-Flow Growth

27.0691

Book-Value Growth

14.5313

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.